Dáil Éireann Debate, Wednesday - 27 February 2019
120. Deputy Bobby Aylward asked the Minister for Health the reimbursement status of the drug Fasenra (benralizumab); if it has been discussed by the HSE drugs leadership group; and if he will make a statement on the matter. [9860/19]
View answerUnder the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for the pricing and reimbursement of medicines; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.
